ANI Pharmaceuticals competitorsClear all
Biosearch Life's top competitors include Olainfarm and Merus.
 Biosearch Life Biosearch Life, a biotechnology company, operates in pharmaceutical, nutraceutical, and functional food sectors internationally. |  Olainfarm Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia. |  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 2000 | Founding Date 1972 | Founding Date 2003 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Granada, ES HQ | Locations Olaine, LV HQ | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 140 | Employees 2,191 | Employees 1833% increase |
Valuation ($) | Valuation ($) 149.2 m | Valuation ($) 150.2 m | Valuation ($) N/A |
Twitter followers | Twitter followers 1.2 k | Twitter followers 717 | Twitter followers N/A |
Alexa Website Rank | Alexa Website Rank 410482 | Alexa Website Rank 110995 | Alexa Website Rank 563795 |
Employee Rating | Employee Rating N/A | Employee Rating 4 | Employee Rating 4.2 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €122.2m (FY, 2020) | Revenue (est.) $49.1m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods (€44.5m) (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €80.1m (FY, 2020) | Gross profit $49.1m (FY, 2021) |
Net income | Net income N/A | Net income €9.5m (FY, 2020) | Net income ($66.8m) (FY, 2021) |
For sources of this data, please see the company profile
View company profiles
Olainfarm
HQ
Olaine, LV
Employees
2,191
Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia.
View companyMerus
HQ
Utrecht, NL
Employees
183↑ 3% increase
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company